Lutris Pharma
Israel
Estabelecido em 2015
1-10 funcionários
Metallurgy, Chemicals, Rubber & Plastics · Tel Aviv-Yafo
Setor / Indústria
Metallurgy, Chemicals, Rubber & Plastics
Descrição da empresa
Lutris Pharma is developing the topical B-Raf inhibitor LUT014, a proprietary small molecule allowing administration of epidermal growth factor receptor (EGFR) inhibitors to patients without the interruptions caused by typical cutaneous side effects. ...
Produtos e serviços
Metallurgy, Chemicals, Rubber & Plastics
PharmaceuticalsHS 30
Material promocional
Para visualizar este conteúdo
Iniciar sessão